Association of soluble interleukin-2 receptor α and tumour necrosis factor receptor 1 with heart failure: The Multi-Ethnic Study of Atherosclerosis.

ESC Heart Failure
Hooman BakhshiJoao A C Lima

Abstract

Soluble tumour necrosis factor-α receptor 1 (sTNF-αR1) and interleukin-2 receptor α (sIL-2Rα) predict incident heart failure (HF) in the elderly population. However, the association of these biomarkers with HF in a multi-ethnic asymptomatic population is unclear. We aimed to investigate the association of sTNF-αR1 and sIL-2Rα with incident HF in a multi-ethnic population of middle age and older participants. The multi-ethnic study of atherosclerosis is a prospective population-based study of 6814 participants aged 45-84 years who were free of clinical cardiovascular disease at enrolment. We included 2869 participants with available sTNF-αR1 or sIL-2Rα level measurement at baseline multi-ethnic study of atherosclerosis exam (2000-2002). We used Cox proportional-hazards model to investigate the association between sTNF-αR1 and sIL-2Rα with incident HF after adjusting for traditional cardiovascular risk factors and coronary artery calcium score measured by cardiac computed tomography. Among the included participants, the mean (standard deviation) age was 61.6 (10.2) years and 46.7% were men. The median (interquartile range) sTNF-αR1 and sIL-2Rα were 1293 (1107-1547) and 901 (727-1154) pg/mL. During a median follow-up of 14.2 (inte...Continue Reading

References

Jul 26, 1990·The New England Journal of Medicine·B LevineM Packer
Apr 2, 2002·Cardiovascular Research·William S BradhamFrancis G Spinale
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Hajime FunakoshiAkira Takeshita
Oct 25, 2002·American Journal of Epidemiology·Diane E BildRussell P Tracy
Aug 29, 2003·The American Journal of Cardiology·Matteo CesariMarco Pahor
Jun 24, 2004·American Journal of Physiology. Heart and Circulatory Physiology·C BerthonnecheP Janiak
Apr 14, 2009·Heart Failure Reviews·Biykem BozkurtAnita Deswal
May 8, 2010·Journal of the American College of Cardiology·Andreas KalogeropoulosUNKNOWN Health ABC Study Investigators
Oct 7, 2010·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Steven M KawutDavid A Bluemke
Nov 16, 2010·Journal of Molecular and Cellular Cardiology·Veli K TopkaraDouglas L Mann
Dec 23, 2011·International Heart Journal·Kazuaki MatsumotoMitsuaki Isobe
May 15, 2013·Journal of Cardiovascular Translational Research·Justin Hartupee, Douglas L Mann
Aug 19, 2014·Journal of Cellular and Molecular Medicine·Zhang-Wei ChenJun-Bo Ge
Mar 31, 2015·Circulation Research·Douglas L Mann
Aug 22, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Peter DurdaLeslie A Lange
Apr 22, 2017·Journal of the American Heart Association·Hooman BakhshiJoão A C Lima
Jun 5, 2017·Archives of Medical Research·Luis Sánchez-TrujilloGuillermo Torre-Amione
Jul 8, 2018·Science Immunology·Abul K AbbasJeffrey A Bluestone

❮ Previous
Next ❯

Citations

May 23, 2021·Acta Physiologica·Almudena Val-BlascoMaria Fernández-Velasco

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Stata

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.